Literature DB >> 24496101

Foxd1 is a mediator and indicator of the cell reprogramming process.

Makito Koga1, Mitsuhiro Matsuda1, Teruhisa Kawamura2, Takahiro Sogo3, Asako Shigeno2, Eisuke Nishida4, Miki Ebisuya5.   

Abstract

It remains unclear how changes in gene expression profiles that establish a pluripotent state are induced during cell reprogramming. Here we identify two forkhead box transcription factors, Foxd1 and Foxo1, as mediators of gene expression programme changes during reprogramming. Knockdown of Foxd1 or Foxo1 reduces the number of iPSCs, and the double knockdown further reduces it. Knockout of Foxd1 inhibits downstream transcriptional events, including the expression of Dax1, a component of the autoregulatory network for maintaining pluripotency. Interestingly, the expression level of Foxd1 is transiently increased in a small population of cells in the middle stage of reprogramming. The transient Foxd1 upregulation in this stage is correlated with a future cell fate as iPSCs. Fate mapping analyses further reveal that >95% of iPSC colonies are derived from the Foxd1-positive cells. Thus, Foxd1 is a mediator and indicator of successful progression of reprogramming.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24496101     DOI: 10.1038/ncomms4197

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  30 in total

1.  FOXD1 predicts prognosis of colorectal cancer patients and promotes colorectal cancer progression via the ERK 1/2 pathway.

Authors:  Fengping Pan; Minjiang Li; Wenbin Chen
Journal:  Am J Transl Res       Date:  2018-05-15       Impact factor: 4.060

Review 2.  The multisystemic functions of FOXD1 in development and disease.

Authors:  Paula Quintero-Ronderos; Paul Laissue
Journal:  J Mol Med (Berl)       Date:  2018-06-29       Impact factor: 4.599

3.  Diagnostic and prognostic value of FOXD1 expression in head and neck squamous cell carcinoma.

Authors:  Shijie Qiu; Dan Li; Zhisen Shen; Qun Li; Yi Shen; Hongxia Deng; Yidong Wu; Chongchang Zhou
Journal:  J Cancer       Date:  2021-01-01       Impact factor: 4.207

4.  Induction of Pluripotency in Astrocytes through a Neural Stem Cell-like State.

Authors:  May Nakajima-Koyama; Joonseong Lee; Sho Ohta; Takuya Yamamoto; Eisuke Nishida
Journal:  J Biol Chem       Date:  2015-11-09       Impact factor: 5.157

5.  Cellular reprogramming dynamics follow a simple one-dimensional reaction coordinate.

Authors:  Sai Teja Pusuluri; Alex H Lang; Pankaj Mehta; Horacio Castillo
Journal:  Phys Biol       Date:  2017-10-04       Impact factor: 2.583

6.  A novel mouse model of hemangiopericytoma due to loss of Tsc2.

Authors:  Heng Du; John R Dreier; Mahsa Zarei; Chin-Lee Wu; Roderick W Bronson; David J Kwiatkowski
Journal:  Hum Mol Genet       Date:  2018-12-15       Impact factor: 6.150

7.  Cellular reprogramming dynamics follow a simple 1D reaction coordinate.

Authors:  Sai Teja Pusuluri; Alex H Lang; Pankaj Mehta; Horacio E Castillo
Journal:  Phys Biol       Date:  2017-12-06       Impact factor: 2.583

8.  FOXD1-ALDH1A3 Signaling Is a Determinant for the Self-Renewal and Tumorigenicity of Mesenchymal Glioma Stem Cells.

Authors:  Peng Cheng; Jia Wang; Indrayani Waghmare; Stefania Sartini; Vito Coviello; Zhuo Zhang; Sung-Hak Kim; Ahmed Mohyeldin; Marat S Pavlyukov; Mutsuko Minata; Claudia L L Valentim; Rishi Raj Chhipa; Krishna P L Bhat; Biplab Dasgupta; Concettina La Motta; Madhuri Kango-Singh; Ichiro Nakano
Journal:  Cancer Res       Date:  2016-08-28       Impact factor: 12.701

9.  MicroRNA-338-5p plays a tumor suppressor role in glioma through inhibition of the MAPK-signaling pathway by binding to FOXD1.

Authors:  Xin-Long Ma; Feng Shang; Wei Ni; Jin Zhu; Bin Luo; Yu-Qi Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2018-09-17       Impact factor: 4.553

10.  Complex Interplay of Genes Underlies Invasiveness in Fibrosarcoma Progression Model.

Authors:  Michaela Kripnerová; Hamendra Singh Parmar; Jiří Šána; Alena Kopková; Lenka Radová; Sieghart Sopper; Krzysztof Biernacki; Jan Jedlička; Michaela Kohoutová; Jitka Kuncová; Jan Peychl; Emil Rudolf; Miroslav Červinka; Zbyněk Houdek; Pavel Dvořák; Kateřina Houfková; Martin Pešta; Zdeněk Tůma; Martina Dolejšová; Filip Tichánek; Václav Babuška; Martin Leba; Ondřej Slabý; Jiří Hatina
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.